Static Chart NeuroSense Therapeutics Ltd.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-31 EDT			5-day change	1st Jan Change
1.08 ^USD	-0.46%		-7.46%	+37.58%

05-14	NeuroSense Partners with PhaseV for ALS Treatment Trial -- Shares Up	MT
05-07	NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients	CI

Duration

Period